Escalier

News

Escalier Biosciences, a privately-held biopharma company based in The Netherlands, has raised $19 million to help advance its pipeline.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.